Kirk E. Cahill, MD

home / authors / kirk-e-cahill-md

Articles

Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular Lymphoma

Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular Lymphoma

Kirk E. Cahill, MD;Sonali Smith, MD
July 12th 2022

Kirk E. Cahill, MD, and Sonali M. Smith, MD, spoke with CancerNetwork® about their review of the current management and treatment of follicular lymphoma published in the journal ONCOLOGY®.

Follicular Lymphoma: a Focus on Current and Emerging Therapies

Follicular Lymphoma: a Focus on Current and Emerging Therapies

Kirk E. Cahill, MD;Sonali M. Smith, MD
February 17th 2022

This review article written by Kirk E. Cahill, MD, and Sonali M. Smith, MD, discusses standard and emerging therapies for the treatment of follicular lymphoma.

Latest Updated Articles

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
A 58-Year-Old Woman on Gemcitabine Developed Swelling and Erythema of Both Legs
Published: August 2nd 2011 | Updated: January 21st 2025
A 58-Year-Old Woman on Gemcitabine Developed Swelling and Erythema of Both Legs
8
Published: January 13th 2025 | Updated: January 21st 2025
Do We Start Luspatercept at the Highest Dose and Titrate Down or Start Low and Titrate Up?